Hewlett Packard Enterprise (HPE) has patched a maximum-severity vulnerability in its HPE OneView software that enables attackers to execute arbitrary code remotely. OneView is HPE's infrastructure ...
Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...
SAN FRANCISCO, Dec 4 (Reuters) - Palantir Technologies (PLTR.O), opens new tab, Nvidia (NVDA.O), opens new tab and U.S. utility CenterPoint Energy (CNP.N), opens new tab on Thursday said they are ...
I came across your Ubuntu desktop tutorial on GitHub, and I have a few questions regarding the provided Ubuntu root file system: (1) Does the provided Ubuntu root file system support GPU rendering? (2 ...
Thoma Bravo is acquiring Verint Systems Inc., a provider of contact center automation software, for $2 billion including debt. The announcement of the deal today came less a week after the private ...
Cisco is warning about a critical remote code execution (RCE) vulnerability in the RADIUS subsystem of its Secure Firewall Management Center (FMC) software. Cisco FCM is a management platform for the ...
RISC-V is an open architecture standard that provides flexibility, and chip designers can add or remove instructions as they please to match their application requirements. That’s all great until ...
The 24.04 ubuntu desktop image has no App Center installed by default. The tutorial after starting the instance tells you to open the app center and simply nothing happens because it's not there. when ...
Trend Micro Inc. today introduced a line of data center appliances with preinstalled cybersecurity and artificial intelligence features. Tokyo-based Trend Micro is a major cybersecurity provider with ...
Ubuntu has long stood as a bastion of accessibility, polish, and power in the Linux ecosystem. With the arrival of Ubuntu 25.04, codenamed “Plucky Puffin”, Canonical has once again demonstrated its ...
Exploratory biomarker analysis of trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in HER2-low/ultralow, hormone receptor–positive (HR+) metastatic breast cancer (mBC) in ...